Patients with Primary Central Nervous System Lymphoma Not Eligible for Clinical Trials: Prognostic Factors, Treatment and Outcome

Patients with Primary Central Nervous System Lymphoma Not Eligible for Clinical Trials: Prognostic Factors, Treatment and Outcome

Patients with primary central nervous system lymphoma (PCNSL) not fulfilling inclusion criteria for clinical trials represent an underreported population. Thirty-four consecutive PCNSL patients seen at our center between 2005 and 2019 with exclusion criteria for therapeutic trials were analyzed (non...

Full description

Bibliographic Details
Main Authors: Sabine Seidel, Michelle Margold, Thomas Kowalski, Alexander Baraniskin, Roland Schroers, Agnieszka Korfel, Eckhard Thiel, Michael Weller, Peter Martus, Uwe Schlegel
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
primary central nervous system lymphoma
polychemotherapy
high-dose methotrexate
cytarabine
Bonn protocol
non-study patients
Online Access:https://www.mdpi.com/2072-6694/13/12/2934

Internet

https://www.mdpi.com/2072-6694/13/12/2934

Similar Items